Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_05-md-01699/USCOURTS-cand-3_05-md-01699-964/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

-1-

STIPULATION AND PRETRIAL ORDER NO. 28: FIRST SUPPLEMENTAL 

STIPULATED PROTECTIVE ORDER – M:05-CV-01699-CRB 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

SAN FRANCISCO DIVISION 

IN RE: BEXTRA AND CELEBREX 

MARKETING SALES PRACTICES AND 

PRODUCT LIABILITY LITIGATION 

CASE NO. M:05-CV-01699-CRB 

MDL No. 1699 

This Order Relates to: 

 ALL CASES. 

STIPULATION AND PRETRIAL ORDER NO. 

28: FIRST SUPPLEMENTAL STIPULATED 

PROTECTIVE ORDER

I. SCOPE OF ORDER 

1. Order Applicable to All Cases in MDL Proceedings. This order shall apply to all 

cases currently pending in MDL No. 1699 and to all related actions that have been or will be 

originally filed in, transferred to, or removed to this Court and assigned thereto (collectively, “the 

MDL proceedings”). This Order is binding on all parties and their counsel in all cases currently 

pending or subsequently made a part of these proceedings and shall govern each case in the 

proceedings unless it explicitly states that it relates only to specific cases. This Order also shall 

apply to discovery provided by PBMs and TPAs (as defined below) pursuant to subpoena. 

2. Original Protective Order Remains in Effect. This Order is intended to supplement 

and not to replace “PRETRIAL ORDER NO. 3: STIPULATED PROTECTIVE ORDER” entered 

by the Court, dated February 7, 2006 (“Original Protective Order”). All provisions of the 

Original Protective Order shall remain in full force and effect except as specified in this Order. 

Case 3:05-md-01699-CRB Document 2297 Filed 03/26/08 Page 1 of 6
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

-2-

STIPULATION AND PRETRIAL ORDER NO. 28: FIRST SUPPLEMENTAL 

STIPULATED PROTECTIVE ORDER – M:05-CV-01699-CRB 

3. Definitions. All terms defined in the Original Protective Order shall have the same 

meaning when used herein. As used herein, the following terms shall have the following 

meanings: 

 a. “Health Plan” shall refer to any Plaintiff or purported class member in the 

MDL proceedings engaged in the business of providing health insurance or health care benefits. 

 b. “Third Party Administrator” or “TPA” shall refer to any person or entity 

that contracts with a Health Plan to administer or manage the business and operations of the 

Health Plan in whole or in part, including by contracting with a Pharmacy Benefit Manager or 

otherwise. 

 c. “Pharmacy Benefit Manager” or “PBM” shall refer to any person or entity 

that contracts with a Health Plan or TPA to provide pharmacy benefit management services. 

II. “HIGHLY CONFIDENTIAL – ATTORNEYS’ EYES ONLY” DESIGNATION 

4. Designation of Highly Confidential Information. Any Confidential Information, as 

defined in the Original Protective Order, furnished to a party in conjunction with this litigation 

that contains non-public information regarding: 

a. contracts (i) between Health Plans, TPAs, plan sponsors, coalitions, or 

other entities and PBMs, or (ii) between Health Plans or PBMs and pharmaceutical 

manufacturers, or other documents containing pricing, rebate, or discount information, that the 

producing party determines in good faith will harm its competitive position if disclosed to a 

competitor or customer of the producing party; or 

b. considerations, deliberations, recommendations, or determinations of 

“pharmacy and therapeutics committees” of PBMs or other persons or committees regarding the 

inclusion of Celebrex or Bextra or other non-steroidal anti-inflammatory drugs (“NSAIDs”) on 

formularies; or 

c. business strategies or financial matters that the producing party determines 

in good faith qualify as trade secrets that would harm its competitive position if disclosed to a 

competitor or customer of the producing party; 

///// 

Case 3:05-md-01699-CRB Document 2297 Filed 03/26/08 Page 2 of 6
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

-3-

STIPULATION AND PRETRIAL ORDER NO. 28: FIRST SUPPLEMENTAL 

STIPULATED PROTECTIVE ORDER – M:05-CV-01699-CRB 

may be designated by the Supplying Party as “HIGHLY CONFIDENTIAL – ATTORNEYS’ 

EYES ONLY.” 

5. Scope of Material Subject to Highly Confidential Information Designation. The 

provisions of this Order extend to all documents or information designated “HIGHLY 

CONFIDENTIAL – ATTORNEYS’ EYES ONLY” regardless of the manner in which it is 

disclosed, including, but not limited to, documents, interrogatory answers, responses to requests 

for admissions, deposition transcripts, deposition exhibits, and any other discovery materials 

produced in response to or in connection with any discovery in the MDL proceedings, and any 

copies, notes, abstracts, or summaries of the foregoing materials. Paragraph 28 of the Original 

Protective Order shall extend to inadvertently produced Highly Confidential Information. 

6. Treatment of Highly Confidential Information. The party receiving documents or 

information designated “HIGHLY CONFIDENTIAL – ATTORNEYS’ EYES ONLY” (A) shall 

treat it as CONFIDENTIAL pursuant to the terms of the Original Protective Order and (B) shall 

not use or disclose the documents and information except in compliance with the terms of this 

Order or such orders as may be issued by the Court during the course of this litigation. Any party 

may challenge the designation of any discovery material as “HIGHLY CONFIDENTIAL – 

ATTORNEYS’ EYES ONLY” by seeking first to resolve the issue by negotiation with the 

Supplying Party, and thereafter by motion seeking appropriate relief. 

7. Disclosure of Highly Confidential Information. Notwithstanding any other 

provision of this Order or the Original Protective Order, no party or other person or entity 

receiving “HIGHLY CONFIDENTIAL – ATTORNEYS’ EYES ONLY” documents or 

information shall reveal, disclose, or produce said documents or any information contained 

therein, except to: (a) the Court and its support personnel, in compliance with paragraph 30 of the 

Original Protective Order; (b) outside counsel retained specifically for this action, including any 

paralegal, clerical and other assistant employed by such counsel and assigned to this matter; 

(c) stenographers engaged to transcribe depositions conducted in this action; (d) any person 

retained by a party to serve as an expert witness or otherwise provide specialized advice to 

counsel in connection with this action, provided such expert is not a current employee of any 

Case 3:05-md-01699-CRB Document 2297 Filed 03/26/08 Page 3 of 6
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

-4-

STIPULATION AND PRETRIAL ORDER NO. 28: FIRST SUPPLEMENTAL 

STIPULATED PROTECTIVE ORDER – M:05-CV-01699-CRB 

party, a customer of the producing party, a pharmaceutical manufacturer, a health benefit plan, or 

a business engaged in providing, administering, or managing health insurance, health care 

benefits, or pharmaceutical benefits (whether such business be a plaintiff, defendant, or nonparty); and (e) a party or non-party witness who may be examined and may testify concerning 

such “HIGHLY CONFIDENTIAL – ATTORNEYS’ EYES ONLY” information if it appears 

from its face or from other documents that the witness is the author or recipient of such 

information. 

 8. Signature of Acknowledgment Prior to Disclosure of Highly Confidential 

Information. Prior to the disclosure of any “HIGHLY CONFIDENTIAL – ATTORNEYS’ EYES 

ONLY” information to any person identified in paragraph 7(d) - (e), each putative recipient of 

“HIGHLY CONFIDENTIAL – ATTORNEYS’ EYES ONLY” information shall be provided 

with copies of the Original Protective Order and this Protective Order, which he or she shall read. 

Upon reading the Protective Orders, such person shall sign an Acknowledgment, in the form 

annexed hereto as Exhibit A, acknowledging that he or she has read the Protective Orders and 

shall abide by their terms. These Acknowledgments are strictly confidential and are to be 

maintained in accordance with paragraph 23 of the Original Protective Order. 

IT IS SO STIPULATED. 

Dated: March 25, 2008 LIEFF CABRASER HEIMANN & BERNSTEIN LLP

By /s/ 

 ELIZABETH J. CABRASER 

Plaintiffs’ Liaison Counsel 

Dated: March 25, 2008 DLA PIPER US LLP

By /s/ 

 AMY W. SCHULMAN 

 Defendants’ Liaison Counsel 

Case 3:05-md-01699-CRB Document 2297 Filed 03/26/08 Page 4 of 6
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

-5-

STIPULATION AND PRETRIAL ORDER NO. 28: FIRST SUPPLEMENTAL 

STIPULATED PROTECTIVE ORDER – M:05-CV-01699-CRB 

PURSUANT TO STIPULATION, IT IS SO ORDERED. 

Dated: March 26, 2008 /s/ 

HONORABLE CHARLES R. BREYER 

UNITED STATES DISTRICT JUDGE 

Case 3:05-md-01699-CRB Document 2297 Filed 03/26/08 Page 5 of 6
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

-6-

STIPULATION AND PRETRIAL ORDER NO. 28: FIRST SUPPLEMENTAL 

STIPULATED PROTECTIVE ORDER – M:05-CV-01699-CRB 

EXHIBIT A

ACKNOWLEDGMENT AND AGREEMENT TO BE BOUND

The undersigned agrees: 

 I declare under penalty of perjury that I have read in their entirety and understand the 

Stipulated Protective Order and the First Supplemental Stipulated Protective Order that were 

issued by the United States District Court for the Northern District of California on February 7, 

2006, and _________________ [date], 2008, respectively (collectively the “Stipulated Protective 

Orders”), in In Re: Bextra and Celebrex Marketing, Sales Practices and Product Liability 

Litigation, MDL No. 1699. I agree to comply with and to be bound by all the terms of the 

Stipulated Protective Orders and I understand and acknowledge that failure to so comply could 

expose me to sanctions and punishment in the nature of contempt. I solemnly promise that I will 

not disclose in any manner any information or item that is subject to the Stipulated Protective 

Orders to any person or entity except in strict compliance with the provisions of the Orders. 

 I further agree to submit to the jurisdiction of the United States District Court for the 

Northern District of California for the purpose of enforcing the terms of the Stipulated Protective 

Orders, even if such enforcement proceedings occur after termination of these proceedings. 

 I hereby appoint __________________________________________________ [print or 

type full name] of _______________________________________________________________ 

______________________________________________________________________________ 

[print or type full address and telephone number] as my California agent for service of process in 

connection with this action or any proceedings related to enforcement of this Stipulated Protective 

Order. 

Date: _____________________________________ 

City and State where sworn and signed: __________________________________ 

Printed name: _____________________________________________ 

 [printed name] 

Signature: _____________________________________________ 

 [signature] 

Case 3:05-md-01699-CRB Document 2297 Filed 03/26/08 Page 6 of 6